UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063093
Receipt number R000072221
Scientific Title Development of a feasible methodology for co-production personalized newborn skin care plans
Date of disclosure of the study information 2026/09/29
Last modified on 2026/09/29 12:15:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a feasible methodology for co-production personalized newborn skin care plans

Acronym

Co-production personalized newborn skin care plans

Scientific Title

Development of a feasible methodology for co-production personalized newborn skin care plans

Scientific Title:Acronym

co-production personalized newborn skin care plans

Region

Japan


Condition

Condition

Healthy infants

Classification by specialty

Nursing Not applicable Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will develop a communication tool to facilitate discussions between parents and healthcare professionals regarding infants' skincare, taking into account differences in infants' skin conditions, allergic factors, environmental conditions, and skincare habits in various regions and households. We will then implement a program for creating skincare plans using this tool and evaluate parents' confidence in childcare, their adherence to the skincare regimen, and the infants' skin conditions to assess the tool's practicality.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Karitane Parenting Confidence Scale: KPCS

Key secondary outcomes

Skincare adherence
Presence or absence of skin problems
Skin barrier function (transepidermal water loss [TEWL], stratum corneum hydration [SCH], sebum levels, and skin surface pH)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

A program using a co-production personalized newborn skin care plans

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

6 months-old >=

Gender

Male and Female

Key inclusion criteria

Infants under 6 months of age and their parents

Key exclusion criteria

Parent(s) who are unable to visit the study site.
Parent(s) with difficulty reading, writing, or communicating in Japanese.

Infants diagnosed with and currently receiving treatment for congenital skin disorders or atopic dermatitis.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Megumi
Middle name
Last name Haruna

Organization

The University of Tokyo

Division name

Department of Women's Health and Midwifery

Zip code

113-0033

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5841-3396

Email

boseikango@m.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Yonezawa

Organization

The University of Tokyo

Division name

Department of Women's Health and Midwifery

Zip code

113-0033

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5841-3396

Homepage URL


Email

boseikango@m.u-tokyo.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Office for Human Research Studies(OHRS), raduate School of Medicine and Faculty of Medicine, The University of Tokyo

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 09 Month 28 Day

Date of IRB

2026 Year 08 Month 26 Day

Anticipated trial start date

2026 Year 09 Month 29 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 29 Day

Last modified on

2026 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072221